A Prospective Analysis of Biofilm in Urinary Catheters Study
A Prospective Anaylsis of Biofilm in Urinary Catheters Study
1 other identifier
observational
9
1 country
1
Brief Summary
To analyze biofilm obtained from at least 10 Subjects who have an indwelling catheter. A 30cc urine sample would also be collected from the same subject, and analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 4, 2013
CompletedFirst Posted
Study publicly available on registry
November 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 11, 2015
December 1, 2015
2.8 years
March 4, 2013
December 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To analyze biofilm obtained from at least 10 Subjects who have an indwelling catheter.
the proteomics, metabolomics and metagenomics ("omics") data will be analyzed and integrated in order to understand the microbial population dynamics and the interactions with the human subject host responses which may include antibacterial defenses, local inflammation, immune tolerance towards bacteria
Over a period of 20 weeks
Eligibility Criteria
Subjects who require a standard foley catheter.
You may qualify if:
- Subject must be 18 years of age.
- Subject is attending weekly office visits at SW Wound Care Center as an out- patient.
- Subject must have an indwelling Foley catheter.
- Subject is informed about the trial, understands its nature of the study and provides written informed consent prior to study enrollment.
- Subject is willing and able to comply with all specified care and visit requirements.
You may not qualify if:
- \. Subject refuses to participate in the study. 2. Subject is expected to be non-compliant. 3. Subject is a resident in a nursing home, or institutionalized. 4. Subject is pregnant. 5. Subject has a Legally Authorized Representative
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Southwest Regional Wound Care Center
Lubbock, Texas, 79410, United States
Biospecimen
A 30cc urine sample would also be collected, along with the used catheter. The molecular evaluation will be looking specifically at the biofilm accumulated on the catheter surface. The technologies to be used are proteomics, metabolomics and metagenomics.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randall Wolcott, M.D.
Southwest Regional Wound Care Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2013
First Posted
November 19, 2013
Study Start
March 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
December 11, 2015
Record last verified: 2015-12